Aggg William Davis once again get its wrong. The $50 top came from news of the early cancer trials and moving to phase 3. This drug is years away but looks good. Suvorexant is already priced in but 2nd qtr numbers will not be good so price is $47 and maybe $48 is the top of 2013. MRK needs drugs not layoffs and restructure.